A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas

Clinical trial NCT01782313 · COMPLETED

Trial details

NCT number: NCT01782313
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma

Start date: 2013-03-06
Primary completion: 2015-05-27
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.